Related Experiment Video
Updated: Oct 29, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Advances in targeting the WNT/β-catenin signaling pathway in cancer
Avradip Chatterjee1, Sayan Paul2, Bharti Bisht3
1Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Abstract:
WNT/β-catenin signaling orchestrates various physiological processes, including embryonic development, growth, tissue homeostasis, and regeneration. Abnormal WNT/β-catenin signaling is associated with various cancers and its inhibition has shown effective antitumor responses. In this review, we discuss the pathway, potential targets for the development of WNT/β-catenin inhibitors, available inhibitors, and their specific molecular interactions with the target proteins. We also discuss inhibitors that are in clinical trials and describe potential new avenues for therapeutically targeting the WNT/β-catenin pathway. Furthermore, we introduce emerging strategies, including artificial intelligence (AI)-assisted tools and technology-based actionable approaches, to translate WNT/β-catenin inhibitors to the clinic for cancer therapy.
Insights
WNT/β-catenin signaling is crucial for development and homeostasis but drives cancer when abnormal. This review covers WNT/β-catenin inhibitors, their clinical progress, and novel AI-driven strategies for cancer therapy.
Area of Science:
- Molecular Biology
- Oncology
- Drug Discovery
Background:
- WNT/β-catenin signaling regulates fundamental physiological processes like development and tissue repair.
- Dysregulation of this pathway is implicated in various cancers, making it a key therapeutic target.
- Inhibiting WNT/β-catenin signaling has demonstrated promising anti-cancer effects.
Purpose of the Study:
- To review the WNT/β-catenin signaling pathway and its role in cancer.
- To discuss current and emerging WNT/β-catenin inhibitors, including their molecular targets and interactions.
- To explore novel therapeutic strategies and AI-assisted approaches for targeting this pathway in cancer treatment.
Main Methods:
- Literature review of WNT/β-catenin signaling pathway.
- Analysis of existing and investigational WNT/β-catenin inhibitors.
- Exploration of artificial intelligence applications in drug development for this pathway.
Main Results:
- The WNT/β-catenin pathway is a validated target in oncology.
- Several inhibitors are available, with many undergoing clinical trials.
- AI and technology-based strategies offer new avenues for therapeutic development.
Conclusions:
- Targeting the WNT/β-catenin pathway holds significant therapeutic potential for cancer.
- Continued research into inhibitors and novel strategies is crucial for clinical translation.
- AI integration may accelerate the development of effective WNT/β-catenin-targeted cancer therapies.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

